Integra Plus Capsule
Pricing Report NDC 52747-712-30

Current NADAC: $0.76501 per EA · Effective Oct 01, 2026 · Est. package price $22.95 (30 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Integra Plus (NDC 52747-712-30) is $0.76501 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 01, 2026.

As a a human prescription drug provided by U.s. Pharmaceutical Corporation, this medication is distributed in a 30 CAPSULE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.76501
Per EA

Effective Date
Oct 01, 2026
Billable Units
30 EA
Estimated Package Price
$22.95
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 CAPSULE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.56560 to $0.76501 per EA. Over this 12 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.5656 - $0.7650
Market Volatility
35.26% Variance
Latest Trend
10.01%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 01, 2026 $0.76501 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Oct 01, 2026 $0.72097 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Sep 23, 2026 $0.69538 EAC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Sep 23, 2026 $0.65539 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $0.69492 EAC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 19, 2026 $0.65525 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $0.69483 EAC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jul 22, 2026 $0.65558 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2026 $0.69504 EAC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 17, 2026 $0.65525 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 20, 2026 $0.69464 EAC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2026 $0.65524 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026